Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications

被引:306
作者
Sala, M. [1 ]
Diab, R. [2 ]
Elaissari, A. [1 ]
Fessi, H. [1 ]
机构
[1] Univ Claude Bernard Lyon 1, CNRS, LAGEP UMR 5007, 43 Blvd 11 November 1918, F-69100 Villeurbanne, France
[2] Univ Lorraine, CNRS, SRSMC, UMR 7565, F-54506 Vandoeuvre Les Nancy, France
关键词
Delivery; Dermal; Disease; Ethosomes; Liposomes; Nanocarrier; Nanoparticles; Permeation; Transdermal; Transfersomes; ENHANCED TRANSDERMAL DELIVERY; IN-VIVO EVALUATION; PENETRATION ENHANCERS; CYCLOSPORINE-A; VESICULAR CARRIERS; PERCUTANEOUS PENETRATION; LIPOSOME ENCAPSULATION; TOPICAL APPLICATION; CUTANEOUS DELIVERY; ELASTIC VESICLES;
D O I
10.1016/j.ijpharm.2017.10.046
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During the past decades, lipid nanocarriers are gaining momentum with their multiple advantages for the management of skin diseases. Lipid nanocarriers enable to target the therapeutic payload to deep skin layers or even to reach the blood circulation making them a promising cutting-edge technology. Lipid nanocarriers refer to a large panel of drug delivery systems. Lipid vesicles are the most conventional, known to be able to carry lipophilic and hydrophilic active agents. A variety of lipid vesicles with high flexibility and deformability could be obtained by adjusting their composition; namely ethosomes, transfersomes and penetration enhancer lipid vesicles which achieve the best results in term of skin permeation. Others are designed with the objective to perform higher encapsulation rate and higher stability, such as solid lipid nanoparticles and nanostructured lipid nanocarriers. In this review, we attempted to give an overview of lipid based nanocarriers developed with the aim to enhance dermal and transdermal drug delivery. A special focus is put on the nanocarrier composition, behavior and interaction mechanisms with the skin. Recent applications of lipid-based nanocarriers for the management of skin diseases and other illnesses are highlighted as well.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 123 条
[1]  
Adib ZM, 2016, ADV PHARM BULL, V6, P31, DOI [10.15171/apb.2016.06, 10.15171/apb.2016.006]
[2]   Testosterone ethosomes for enhanced transdermal delivery [J].
Ainbinder, D ;
Touitou, E .
DRUG DELIVERY, 2005, 12 (05) :297-303
[3]   Approaches for breaking the barriers of drug permeation through transdermal drug delivery [J].
Alexander, Amit ;
Dwivedi, Shubhangi ;
Ajazuddin ;
Giri, Tapan K. ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Tripathi, Dulal Krishna .
JOURNAL OF CONTROLLED RELEASE, 2012, 164 (01) :26-40
[4]   Healthcare professionals' awareness and knowledge of adverse drug reactions and pharmacovigilance [J].
Almandil, Noor B. .
SAUDI MEDICAL JOURNAL, 2016, 37 (12) :1359-1364
[5]  
[Anonymous], 2003, TRANSDERMAL TOPICAL
[6]  
[Anonymous], 2012, J PHARM ALLIED HLTH
[7]   Penetration of metallic nanoparticles in human full-thickness skin [J].
Baroli, Biancamaria ;
Ennas, Maria Grazia ;
Loffredo, Felice ;
Isola, Michela ;
Pinna, Raimondo ;
Arturo Lopez-Quintela, M. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) :1701-1712
[8]  
Baron JM, 2001, CURR OPIN ALLERGY CL, V1, P287, DOI 10.1097/01.all.0000011028.08297.b3
[9]   Interaction of liposome formulations with human skin in vitro [J].
Betz, G ;
Imboden, R ;
Imanidis, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 229 (1-2) :117-129
[10]  
Bhalaria MK, 2009, INDIAN J EXP BIOL, V47, P368